Use access key #2 to skip to page content.
$63.36 6.19 (10.83%)
7/18/2008 1:25 PM

Barr Pharmaceuticals, Inc. (BRL)

CAPS Rating:
*****

A specialty pharmaceutical Company, which is engaged in the development, manufacture and marketing of generic and proprietary pharmaceuticals.

X

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other players to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

You aren't currently rating BRL

Add Stock to Watchlist

What the Community Thinks Add a widget featuring this stock to your blog!

Total Players

829 Outperforms
34 Underperforms
 

All-Stars

293 Outperforms
7 Underperforms
 

Wall Street

9 Outperforms
1 Underperforms
 

Players bullish on BRL are also bullish on:

Players bearish on BRL are also bearish on:

Ticker Tags

Mid Cap (670), S&P 500 (481), Drugs - Generic (14)
Suggest a tag

Barr Pharmaceuticals, Inc. At A Glance

Current Price: $63.36
Last Trade Time: 7/18/2008 1:25 PM
Open: $62.01
Previous Close: $57.17
Daily Range: $61.75 - $64.21
52-Week Range: $37.40 - $58.53
Volume: 30,179,988
Market Cap: $6.18B
P/E Ratio: 40.26
Compare Our Special Broker Offers!

Stock Trends

BRL VS S&P 500 (SPY)

BRL 12 month chart vs. S&P

News & Discussion Boards

Other News Headlines for BRL

More Headlines...

Top Bull Pitch

Recs

1

Barr Pharmaceuticals, Inc. (BRL)

Avatar petejose (71.66) Submitted: 5/08/08 11:58 AM

The basis for owning this (I have real money at a loss right now) is that the industry is in for long, appreciating demand with the population aging and the economy prepared for inflation. Recession money is decently sheltered in basic necessities, such as groceries, utilities, and pharmaceuticals....More

Replies: 0 | Reply | Permalink

Top Bear Pitch

Recs

4

Barr Pharmaceuticals, Inc. (BRL)

Avatar ffishernc (< 20) Submitted: 3/27/07 9:38 PM

Although a well managed company, the major manufacturers are beginning to market their own "generic" versions. The generics are sold ONLY on price. I am afraid that the big boys have enough $ to put the competition on the ropes.

Replies: 1 | Reply | Permalink

CAPS Players

picks per page. CHANGE

Results 1 - 5 of 142 :   1 2 3 4 5 Next » Jump to page:

Recs

0

 (BRL)

Avatar StoxInves (< 20) Submitted: 7/18/08 8:45 AM : Outperform Start Price: $61.75 BRL Score: 3.18

Barr Pharm. manufactures generic products. Is a global company with operation in more than 30 countries. Generic products are generally cheaper than most brand ones. Market is quite huge for cheaper products in the developing nations. 1Year growth is high. Quarterly earnings are good. EPS is not that impressive. But the whole picture may change after if acquisition by Teva occurred.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (BRL)

Avatar tixareforkids (65.81) Submitted: 6/26/08 3:34 PM : Outperform Start Price: $43.07 BRL Score: 49.59

luvb2b is very convincing

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (BRL)

Avatar billtill (96.13) Submitted: 6/26/08 11:51 AM : Outperform Start Price: $43.22 BRL Score: 49.85

generics

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (BRL)

Avatar tom10926 (< 20) Submitted: 6/12/08 2:58 PM : Outperform Start Price: $41.72 BRL Score: 58.33




Understand management

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (BRL)

Avatar ahabswife (86.87) Submitted: 5/22/08 4:42 PM : Outperform Start Price: $42.40 BRL Score: 59.02

Drugs are good.

Report this Post Replies: 0 | Reply | Permalink

Results 1 - 5 of 142 :   1 2 3 4 5 Next » Jump to page:

Wall Street

Results 1 - 10 of 10  

picks per page. CHANGE Expand All Pitches

Top
Pick		Player NamePlayer RatingStart
Date		CallTime FrameStart
Price		Stock
Gain		S&P
Gain		ScorePitch
TrackZacks 93.63 05/23/08 05/23/08 Underperform 3M $42.76+47.94%-8.95%-56.89 Toggle the visibility of 60-Second Pitch and replies
TrackCowenandCo 76.88 05/13/08 05/13/08 Outperform NS $40.98+54.37%-10.74%+65.11
TrackFBR 89.81 02/08/08 02/08/08 Outperform NS $51.07+23.87%-5.84%+29.71
TrackBofASec 96.81 12/18/07 12/18/07 Outperform NS $52.45+20.61%-14.22%+34.83
TrackEdwardOwens 98.93 09/30/07 09/30/07 Outperform NS $56.91+11.16%-17.86%+29.02 Toggle the visibility of 60-Second Pitch and replies
TrackBernstein 76.89 05/10/07 05/10/07 Outperform NS $53.58+18.07%-16.86%+34.92
TrackUBS 96.77 03/23/07 03/23/07 Outperform NS $48.96+29.21%-12.55%+41.76
TrackLehmanBros 90.07 01/31/07 01/31/07 Outperform NS $53.60+18.02%-12.14%+30.16
TrackBarronsRoun 97.88 01/22/07 01/22/07 Outperform 1Y $52.31+20.93%-11.98%+32.91 Toggle the visibility of 60-Second Pitch and replies
TrackMatrix 90.45 10/24/06 10/24/06 Outperform NS $52.50+20.50%-8.71%+29.21
TrackJimCramer 82.41 08/22/06 08/22/06 Underperform 3W $58.28+8.54%-3.69%-12.23

Results 1 - 10 of 10  

X

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.

Featured Broker Partners